Why treat insomnia?

scientific article

Why treat insomnia? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4088/PCC.08R00743BRO
P932PMC publication ID2882812
P698PubMed publication ID20582296

P2093author name stringPhilip Gehrman
Michael L Perlis
Wilfred R Pigeon
Sara E Matteson-Rusby
P2860cites workLong-term follow-up of chronic insomniaQ70896702
Self-reported sleep disturbance as a prodromal symptom in recurrent depressionQ73230264
Insomnia in Young Men and Subsequent Depression: The Johns Hopkins Precursors StudyQ73528843
Who becomes depressed? The Islington community study of older peopleQ73712954
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefitsQ24538295
Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomniaQ24646517
Major Depressive Disorder (MDD) is associated with a primary defect within the serotonergic systemQ30763180
The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic painQ33695720
Insomnia and heart disease: a review of epidemiologic studiesQ33806559
Insomnia: epidemiology, characteristics, and consequencesQ33974032
Prevalence and treatment of insomnia in general practice. A longitudinal study.Q34061310
A cognitive model of insomniaQ34145119
Treatment of chronic insomnia by restriction of time in bed.Q34183910
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacyQ34330624
Does sleep disturbance predict depression in elderly people? A study in inner LondonQ34348545
Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adultsQ34386642
Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomniaQ34482283
Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?Q34541877
Measuring outcomes in randomized clinical trials of insomnia treatmentsQ35202824
Do insomnia complaints cause hypertension or cardiovascular disease?Q35995401
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitationsQ35995568
Discrepancy between subjective symptomatology and objective neuropsychological performance in insomnia.Q35995607
Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?Q36519119
The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical reviewQ36523437
Treating the health, quality of life, and functional impairments in insomniaQ36844267
Cancer-related fatigue and sleep disordersQ36851046
Incidence and risk factors of insomnia in a population-based sample.Q37279090
Intermittent and long-term use of sedative hypnotics.Q37347409
The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies.Q37388190
Insomnia as a risk factor for onset of depression in the elderlyQ38438197
A behavioral perspective on insomnia treatmentQ39702869
Treatment of insomnia in cancer patients using muscle relaxation trainingQ40163657
Treatment of residual insomnia after CBT for PTSD: case studiesQ40373577
Economic effects of insomnia.Q40595288
Secondary insomnia: diagnostic challenges and intervention opportunitiesQ40610274
Sleep complaints and depression in an aging cohort: A prospective perspectiveQ40784276
Identifying effective psychological treatments for insomnia: a meta-analysisQ40995161
An evaluation of progressive muscle relaxation on stress related symptoms in a geriatric populationQ41642024
Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacyQ41673576
Insomnia in primary care patientsQ41677388
Short and long sleep and sleeping pills. Is increased mortality associated?Q44106715
Depression and insomnia.Q44313209
The morbidity of insomnia uncomplicated by psychiatric disordersQ44319923
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depressionQ44395380
Persistent insomnia is a predictor of hypertension in Japanese male workersQ44694024
Persistence and remission of depressive symptoms in late lifeQ44777563
Behavioral management of sleep disturbances secondary to chronic painQ45004883
Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics.Q45022775
Medical and socio-professional impact of insomnia.Q45239747
Sleep problems and their correlates in a working populationQ46153581
The natural history of insomnia: a population-based 3-year longitudinal studyQ48406814
Effects of a brief behavioral treatment for late-life insomnia: preliminary findings.Q48466083
The direct and indirect costs of untreated insomnia in adults in the United StatesQ48472282
A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.Q48475550
A pilot study of cognitive-behavioral therapy of insomnia in people with mild depressionQ48477368
Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitusQ48490097
Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot studyQ48497178
The economic impact of insomnia in managed care: a clearer picture emerges.Q48501412
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorderQ48506440
The economic cost of sleep disorders.Q48508358
Secondary insomnia: a myth dismissedQ48519355
Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trialQ48522790
Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effectsQ48536988
Focusing on the experience of insomniaQ48557296
Cognitive-behavioral group therapy for insomnia in individuals with serious mental illnesses: a preliminary evaluationQ48601739
Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancerQ48635386
Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-upQ48637645
Efficacy of two behavioral treatment programs for comorbid geriatric insomniaQ48659195
Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivorsQ48684266
Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trialQ48685848
Behavioral treatment of insomnia: treatment outcome and the relevance of medical and psychiatric morbidityQ48689778
Relationship between insomnia, depression, and mortality: a 12-year follow-up of older adults in the communityQ48710007
Cognitive-behavioral treatment of insomnia secondary to chronic painQ48718537
Psychological treatment of secondary insomniaQ48718664
The direct economic costs of insomnia in the United States for 1995.Q48755598
Quality of life in people with insomnia.Q48755632
Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.Q48755783
Behavioral treatment of chronic insomnia in psychiatrically ill patientsQ48773151
Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attendersQ48834764
Physical activity and personal characteristics associated with depression and suicide in American college men.Q48854153
Sleep in late-life recurrent depression. Changes during early continuation therapy with nortriptylineQ48899594
Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area ProgramQ48903334
The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomniaQ48930193
Automobile accidents in patients with sleep disordersQ48934059
The treatment of severe insomnia in a cancer patientQ49017117
Behavioral treatment of excessive daytime sleepiness in an elderly woman with multiple medical problemsQ49061589
Therapeutic application of a simple relaxation method.Q51305958
Inpatient multidimensional management of treatment-resistant insomnia.Q52074872
Health-related quality of life in patients with insomnia treated with zopiclone.Q53633945
Residual symptoms in depressed patients who respond acutely to fluoxetine.Q53933212
Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one yearQ69993497
P433issue1
P304page(s)PCC.08r00743
P577publication date2010-01-01
P1433published inPrimary Care Companion to the Journal of Clinical PsychiatryQ15751574
P1476titleWhy treat insomnia?
P478volume12

Reverse relations

cites work (P2860)
Q30397078A pilot study of audio-visual stimulation as a self-care treatment for insomnia in adults with insomnia and chronic pain
Q90457543An Assessment of Medical Practitioners' Knowledge of, Experience with, and Treatment Attitudes Towards Sleep Disorders and Nightmares
Q28395273Associations between Poor Sleep Quality and Stages of Change of Multiple Health Behaviors among Participants of Employee Wellness Program
Q39375201Insomnia as a Precipitating Factor in New Onset Mental Illness: a Systematic Review of Recent Findings
Q90294885Perceived racial discrimination and risk of insomnia among middle-aged and elderly Black women
Q34666714Randomized placebo-controlled trial of cognitive behavioral therapy and armodafinil for insomnia after cancer treatment
Q37627140Short sleep duration and insomnia associated with hypertension incidence
Q93181335The assessment and management of insomnia: an update
Q36117951The options available in cognitive behavioral therapy to prevent chronification of insomnia
Q39799383Wake up to insomnia: future approaches to the management of insomnia

Search more.